Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NKAPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101927826 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZCCHC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
RPN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00869 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PDCD6IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEACAM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM217 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM193B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALPK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ORMDL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on